MoneyWorks4Me

Ipca Laboratories - Quaterly Results

14 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 21192.40 millions grew by 21.31 % from Rs. 17469.00 millions.A good growth in profit of 42.46% reported to Rs. 3732.90  millions over Rs. 2620.40 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 5950.60 millions from 4319.40 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 21192.40 17469.00 21.31 21192.40 17469.00 21.31 73367.50 66779.20 9.87
Other Income 174.20 250.20 -30.38 174.20 250.20 -30.38 946.40 712.90 32.75
PBIDT 5950.60 4319.40 37.76 5950.60 4319.40 37.76 18749.30 15963.20 17.45
Interest 50.40 120.60 -58.21 50.40 120.60 -58.21 435.10 630.40 -30.98
PBDT 5900.20 4198.80 40.52 5900.20 4198.80 40.52 18010.00 12517.40 43.88
Depreciation 746.10 631.30 18.18 746.10 631.30 18.18 2688.70 2519.70 6.71
PBT 5154.10 3567.50 44.47 5154.10 3567.50 44.47 15321.30 9997.70 53.25
TAX 1421.20 947.10 50.06 1421.20 947.10 50.06 3996.10 3490.10 14.50
Deferred Tax 120.00 20.50 485.37 120.00 20.50 485.37 -25.10 81.10 -130.95
PAT 3732.90 2620.40 42.46 3732.90 2620.40 42.46 11325.20 6507.60 74.03
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 28.08 24.73 13.56 28.08 24.73 13.56 25.56 23.90 6.91
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..